In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Chinese employers note boost in role of unions:

This article was originally published in Clinica

Executive Summary

Employee trade unions in China have secured a stronger role in industrial affairs under the updated Labor Contract Law, which is due to come into force on January 1 2008. Employee safety is also more prominent in the new law, which will affect the burgeoning US$4-7bn medtech industry, alongside other industries. As predicted in Clinica (Nos 1202, p 11 & 1233, p 13), the new law makes consultation between employers and trade unions mandatory in a number of areas, such as lay-offs, wages, working hours and other welfare issues. Written contracts for full-time staff are compulsory, and severance pay conditions are improved. Rules to implement the new law will be issued by the labour and social security ministry and relevant local governments over the next few months.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048581

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel